Security key
03969K108
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 123,454,843
- Total 13F shares
- 101,272,913
- Share change
- +28,570,113
- Total reported value
- $327,119,655
- Put/Call ratio
- 163%
- Price per share
- $3.23
- Number of holders
- 130
- Value change
- +$79,248,549
- Number of buys
- 84
- Number of sells
- 65
Report period
Q4 2023
Institutions
130
Top holders
10
ARQT full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
7%
|
8,684,232
|
$46,113,272 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
6.7%
|
8,262,042
|
$43,871,444 | — | 30 Sep 2023 | |
| Rubric Capital Management LP |
13F
|
Company |
4.1%
|
5,034,530
|
$26,733,354 | — | 30 Sep 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
3.6%
|
4,432,175
|
$23,534,851 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.5%
|
4,360,807
|
$23,155,885 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.3%
|
4,020,401
|
$21,348,329 | — | 30 Sep 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.5%
|
3,117,944
|
$16,556,283 | — | 30 Sep 2023 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
2.4%
|
3,000,000
|
$15,930,000 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
2,879,460
|
$15,289,933 | — | 30 Sep 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.9%
|
2,311,077
|
$12,271,818 | — | 30 Sep 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.7%
|
2,069,293
|
$10,988,000 | — | 30 Sep 2023 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
1.6%
|
1,914,479
|
$10,165,883 | — | 30 Sep 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1%
|
1,292,353
|
$6,862,395 | — | 30 Sep 2023 | |
| Holocene Advisors, LP |
13F
|
Company |
0.98%
|
1,204,538
|
$6,396,097 | — | 30 Sep 2023 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.92%
|
1,135,227
|
$6,028,055 | — | 30 Sep 2023 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.9%
|
1,105,309
|
$5,869,191 | — | 30 Sep 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.89%
|
1,104,244
|
$5,863,536 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.84%
|
1,037,946
|
$5,512,202 | — | 30 Sep 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.67%
|
826,095
|
$4,386,565 | — | 30 Sep 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.52%
|
635,969
|
$3,376,995 | — | 30 Sep 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.41%
|
510,094
|
$2,708,597 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
483,499
|
$2,567,380 | — | 30 Sep 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.34%
|
419,309
|
$2,226,531 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
383,813
|
$2,038,047 | — | 30 Sep 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.29%
|
363,415
|
$2,012,534 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
350,963
|
$1,863,613 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.27%
|
333,010
|
$1,768,284 | — | 30 Sep 2023 | |
| Tejara Capital Ltd |
13F
|
Company |
0.25%
|
309,179
|
$1,641,740 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.25%
|
308,949
|
$1,640,519 | — | 30 Sep 2023 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0.23%
|
282,434
|
$1,499,725 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.2%
|
250,535
|
$1,330,341 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
237,779
|
$1,262,606 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.18%
|
222,040
|
$1,179,031 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
219,177
|
$1,163,830 | — | 30 Sep 2023 | |
| Centiva Capital, LP |
13F
|
Company |
0.17%
|
210,000
|
$1,115,100 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
207,077
|
$1,099,579 | — | 30 Sep 2023 | |
| PDT Partners, LLC |
13F
|
Company |
0.16%
|
195,081
|
$1,035,880 | — | 30 Sep 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.14%
|
176,822
|
$938,925 | — | 30 Sep 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.13%
|
165,000
|
$876,150 | — | 30 Sep 2023 | |
| Two Seas Capital LP |
13F
|
Company |
0.13%
|
164,807
|
$875,125 | — | 30 Sep 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.12%
|
143,935
|
$764,295 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.1%
|
127,277
|
$676,255 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.1%
|
123,025
|
$653,263 | — | 30 Sep 2023 | |
| Swiss National Bank |
13F
|
Company |
0.08%
|
101,200
|
$537,372 | — | 30 Sep 2023 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.08%
|
95,308
|
$506,085 | — | 30 Sep 2023 | |
| FISHMAN JAY A LTD/MI |
13F
|
Company |
0.07%
|
87,000
|
$461,970 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.07%
|
86,778
|
$460,791 | — | 30 Sep 2023 | |
| Symmetry Investments LP |
13F
|
Company |
0.07%
|
85,000
|
$451,350 | — | 30 Sep 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.07%
|
83,513
|
$443,454 | — | 30 Sep 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.07%
|
81,080
|
$430,535 | — | 30 Sep 2023 |
Institutional Holders of Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) as of Q4 2023
As of 31 Dec 2023,
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,272,913 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, Frazier Life Sciences Management, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, Rubric Capital Management LP, Polar Capital Holdings Plc, MORGAN STANLEY, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, and Bain Capital Life Sciences Investors, LLC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
131
Q4 2023 holders
130
Holder diff
-1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.